Peer-Reviewed Publications

CPCE investigators are international experts in their clinical effectiveness-related fields, and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here you can access CPCE journal article abstracts by author, title, or year.

Found 74 results
Author Title [ Year(Asc)]
Filters: Author is Li, Yimei  [Clear All Filters]
2015
Lee GE, Fisher BT, Xiao R, et al. "Burden of Influenza-Related Hospitalizations and Attributable Mortality in Pediatric Acute Lymphoblastic Leukemia." J Pediatric Infect Dis Soc. 2015;4(4):290-6.
Miller TP, Troxel AB, Li Y, et al. "Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group." Pediatr Blood Cancer. 2015;62(7):1184-9.
Getz KD, Li Y, Alonzo TA, et al. "Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group." Pediatr Blood Cancer. 2015;62(10):1775-81.
Getz KD, Miller TP, Seif AE, et al. "A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia." Cancer Med. 2015;4(9):1356-64.
Seif AE, Walker DM, Li Y, et al. "Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients." Pediatr Blood Cancer. 2015;62(4):704-9.
Salazar EG, M Bernhardt B, Li Y, Aplenc R, Adamson PC. "The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology Group." Pediatr Blood Cancer. 2015;62(6):940-4.
Li Y, Hall M, Fisher BT, et al. "Merging Children's Oncology Group Data with an External Administrative Database Using Indirect Patient Identifiers: A Report from the Children's Oncology Group." PLoS ONE. 2015;10(11):e0143480.
2014
Fisher BT, Kavcic M, Li Y, et al. "Antifungal prophylaxis associated with decreased induction mortality rates and resources utilized in children with new-onset acute myeloid leukemia." Clin. Infect. Dis.. 2014;58(4):502-8.
Goodman EK, Reilly AF, Fisher BT, et al. "Association of weekend admission with hospital length of stay, time to chemotherapy, and risk for respiratory failure in pediatric patients with newly diagnosed leukemia at freestanding US children's hospitals." JAMA Pediatr. 2014;168(10):925-31.
Desai AV, Kavcic M, Huang YS, et al. "Establishing a high-risk neuroblastoma cohort using the Pediatric Health Information System Database." Pediatr Blood Cancer. 2014;61(6):1129-31.
Fisher BT, Harris T, Torp K, et al. "Establishment of an 11-year cohort of 8733 pediatric patients hospitalized at United States free-standing children's hospitals with de novo acute lymphoblastic leukemia from health care administrative data." Med Care. 2014;52(1):e1-6.
Fisher BT, Singh S, Huang YS, et al. "Induction mortality, ATRA administration, and resource utilization in a nationally representative cohort of children with acute promyelocytic leukemia in the United States from 1999 to 2009." Pediatr Blood Cancer. 2014;61(1):68-73.
Maude SL, Fitzgerald JC, Fisher BT, et al. "Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States." Pediatr Crit Care Med. 2014;15(2):112-20.
Seif AE, Fisher BT, Li Y, et al. "Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemia." Pediatr Blood Cancer. 2014;61(5):846-52.
Freedman JL, Faerber J, Kang TI, et al. "Predictors of antiemetic alteration in pediatric acute myeloid leukemia." Pediatr Blood Cancer. 2014;61(10):1798-805.

Pages